Skip to main content
Springer Nature Link
Log in
Discover
Discover Oncology
Publishing model:
Open access
Submit your manuscript

Collections and calls for papers

Filter by:

New Genomic and Proteomic Biomarker Discovery in Cancer

The Collection will focus on articles related to the development, discovery, and validation of novel biomarkers in cancer. The identification of biomarkers is crucial for diagnosis and precision oncology, en...
Submission status
Open
Submission deadline
14 February 2026

New Paradigms in Radiation Oncology for Gastrointestinal Cancer

Radiation oncology for gastrointestinal cancers is rapidly evolving due to technological innovations and multimodal treatment strategies. However, several clinical and biological challenges remain unresolved...
Submission status
Open
Submission deadline
14 February 2026

Pan-anticancer Strategies Currently Under Exploration

Pan-anticancer strategies refer to therapeutic and/or theragnostic approaches, targeting common biological features shared by various cancer types, rather than focusing on specific mutations or pathways uniq...
Submission status
Open
Submission deadline
14 February 2026

Recurrent and Residual Brain Tumors in the Era of Precision Medicine

Brain tumors, particularly gliomas and other aggressive malignancies, often recur despite initial treatment, posing significant challenges in neuro-oncology. Residual tumor cells that survive surgery, radiat...
Submission status
Open
Submission deadline
30 January 2026

Metabolic Changes and Cancer Risk and Biology

Previously it was thought that cancer and metabolic diseases were two distinct processes. Now it is known that metabolic changes underlie aggressive cancer biology, and that metabolic disease promotes both e...
Submission status
Open
Submission deadline
17 January 2026

Advancing Insights into the Epidemiology of Hematological Cancers

Hematological cancers, comprising leukemia, lymphoma, and myeloma, represent a significant global health challenge, with substantial morbidity and mortality rates. Understanding the epidemiology of these can...
Submission status
Open
Submission deadline
17 January 2026

Advances in Epigenetics in Gastrointestinal Oncology

Epigenetics has emerged as a crucial regulatory mechanism driving tumor initiation, progression, and response to treatment in recent years. Epigenetic alterations - ranging from DNA methylation and histone m...
Submission status
Open
Submission deadline
17 January 2026

Biomarkers and Therapeutic Targets for Central Nervous System Tumors

Central Nervous System (CNS) tumors remain a significant challenge in both research and clinical practice due to their complex biology, limited treatment options, and often poor prognosis. The identification...
Submission status
Open
Submission deadline
07 January 2026

Accelerating Childhood Cancer Diagnosis: Past, Present, and Future

A Collection reviewing the past, present, and future of approaches to accelerating diagnosis of childhood cancer. Our Collection invites review articles on the topic, original research, including systematic ...
Submission status
Open
Submission deadline
19 December 2025

Post-Transcriptional Control of Oncogenesis

Post-transcriptional regulatory mechanisms have emerged as pivotal contributors to cancer biology, modulating tumor initiation, progression, and therapeutic responses. Processes such as alternative splicing,...
Submission status
Open
Submission deadline
19 December 2025

Single-Cell RNA Sequencing in Cancer Immunotherapy

Cancer immunotherapy is a hot area of current oncology research, with its core focus on activating or enhancing the body's immune system's ability to recognize and kill cancer cells. However, cancer cells po...
Submission status
Open
Submission deadline
19 December 2025

Tumor Microenvironment

The immunological and stromal components of the tumor microenvironment (TME) play important roles in supporting or preventing tumor growth. The interaction of tumor cells and immune cells inside the TME is c...
Submission status
Open
Submission deadline
19 December 2025

Mass Spectrometry-Based Proteomic Approaches in Cancer Research

Mass spectrometry (MS)-based proteomics has become an indispensable tool in cancer research, offering high-throughput, quantitative insights into protein expression, post-translational modifications, and pro...
Submission status
Open
Submission deadline
19 December 2025

Cancer Survivorship

It has been estimated that 53.5 million people worldwide live with cancer in 2022. Cancer survivors face many challenges, including medical, physical, psychosocial, and financial issues. Cancer survivors are...
Submission status
Open
Submission deadline
19 December 2025

Big Data in Advancing Cancer Research [Volume II]

Cancer continues to pose a significant threat to human life and health, remaining a highly aggressive and deadly disease. It is a leading cause of death worldwide and presents a critical medical challenge fo...
Submission status
Open
Submission deadline
14 September 2025

Computational Methods in Breast Oncology

Breast cancer comprises 30% of newly diagnosed malignancies in women annually, and remains one of the leading causes of cancer-related deaths worldwide. Treatment and diagnostic approaches for breast cancer ...
Submission status
Open
Submission deadline
14 July 2025

Recent Advances in Oncology Nutrition

Functional food compounds are natural substances found in various foods that have the potential to influence health beyond basic nutritional benefits. These compounds include polyphenols, carotenoids, glucos...
Submission status
Open
Submission deadline
14 July 2025

Therapeutic Targeting Cancer Stem Cells

Cancer stem cells (CSCs) are primarily responsible for tumor aggressive features, including therapeutic resistance, tumor repopulation, and metastasis. Therefore, targeting CSC mediators is extremely require...
Submission status
Open
Submission deadline
14 July 2025

The Metabolic Reprogramming and Its Intervention in Tumorigenesis

This Collection aims to explore the critical role of metabolic reprogramming in cancer stemness, development, progression, and microenvironment. Metabolic reprogramming, characterized by one representative f...
Submission status
Open
Submission deadline
14 July 2025

Deciphering Molecular Bases of Hormone-responsive Breast Cancers

Breast cancer remains the most frequent neoplasia in women with a profound heterogeneity in disease progression and response to therapies, mainly relying on the expression of hormone receptors. In fact, abou...
Submission status
Open
Submission deadline
14 July 2025

Immunogenic Modulators for Cancer Treatment

Immunogenic modulators influence the immune system's response to an antigen. They can enhance, alter, or suppress the immune response to improve the disease's symptoms. Immune checkpoints are cell surface mo...
Submission status
Open
Submission deadline
03 July 2025

Real-World Data in Leukemia

This collection explores the burgeoning field of Real-World Data (RWD) and its critical applications in leukemia research, reflecting the comprehensive approach taken by Discover Oncology. Recognizing that c...
Submission status
Open
Submission deadline
22 August 2025

Advances in the Pathophysiological Mechanisms of Oral Cancer

Oral cancer is one of the top ten most prevalent cancers globally, affecting millions annually and contributing significantly to cancer-related morbidity and mortality. Despite advancements in diagnostics an...
Submission status
Open
Submission deadline
13 July 2025

Advances in GU Cancers: From Carcinogenesis to New Therapies

Genitourinary cancers include a large number of pathological entities, including some of the most commonly diagnosed cancers worldwide such as prostate cancer and also rare lesions like vulvar and penile can...
Submission status
Open
Submission deadline
01 August 2025

Environmental Stress Induced Aneuploidy and Cancer

Environmental factors wield their influence on cellular homeostasis through myriad of mechanisms that provide a vital link between genome maintenance and disease. The intricate gene-environment interaction i...
Submission status
Open
Submission deadline
31 October 2025

The Role of Retroviral Elements in Cancer

Sequences of viral origin known as retroviral elements are present in the human genome and can potentially impact biological processes, such as cancer development. These elements, particularly endogenous ret...
Submission status
Open
Submission deadline
15 July 2025

Metastatic Cancer: Organ-Specific Metastasis

Metastasis is the most devastating stage of cancer progression and is responsible for the majority of cancer-related deaths. Metastasis is a process by which cancer cells are dispersed from the original site...
Submission status
Open
Submission deadline
30 September 2025

Journal navigation